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ABSTRACT : Cissus quadrangularis L. variant II belonging to the family Vitaceae was screened 
for its activity Hellcobacter pylori (Hp) human isolates.  Flowering and vegetative period 
samples were analyzed.  Aqueous (hot and cold) and solvent extracts (acetone, chloroform and 
methanol) were screened.  Among them chloroform was observed to recover bioactive principles 
with low MIC and MLC.  MIC and MLC was 40 µg/ml for flowering period.  Whereas for 
vegetative period MIC was 40 µg/ml and MLC was 40 µg/ml respectively.  Extracts from 
samples collected during flowering period were better than that of vegetative period.  The results 
confirm the traditional use of the plant in PUD. 
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INTRODUCTION 
 
Helicobacter pylori (Hp) is an important 
etiological factor in chronic gastritis and 
peptic ulcer diseases
1.  Drugs of Hp 
eradication are available but are costly and 
have documented side effects
2.  Plants are 
not reported for their helicobacericidal 
activity yet.  So, in this view, a plant used 
for treating ulcer traditionally viz., Cissus 
quadrangularis
3,4 was screened for its 
helicobatericidal activity.  Three 
morphovariants of this plant viz., square-
stemmed, round-stemmed and flat-stemmed 
are available and differentiated as variant I, 
II and III respectively.  Variant I is a 
common plant widely distributed in hotter 
parts of India widely used and studied for 
gastric problems
5, 6.  The round-stemmed 
variety (variant II) is not much studied
7, 
which is also considered to be a plant for 
gastric ulcer.  The antiulcer potential of this 
plant has been carried out 
pharmacologically
8.  Hence, microbiological 
screening for its helicobactericidal activity 
was carried out. 
 
MATERIALS AND METHODS 
 
C.quadrangularis L. variant II (Vitaceae) 
was identified according to standard 
methods
9.  A voucher specimen has been 
deposited in the department for future 
reference (TU 190). C.quadrangularis  
variant II was collected form the herbal 
garden of Tamil University, Thanjavur, 
Tamilnadu, India.  Two seasonal samples 
were collected i.e., flowering in the month 
of April (2000) and vegetative during 
October (2000) with a difference of six 
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months between the periods of sample 
collection
9.  Plant samples were shade dried, 
pulverized, filtered (40 mm  mesh) and 
stored.  Aqueous extracts (hot and cold) and 
solvent extracts (Acetone, Chloroform and 
Ethanol) were prepared according to 
standard methods
10. 
 
Human isolates of H.pylori were collected 
from gastic antral biopsy specimens at the 
site of active lesions with the help of sterile 
(2% gluteraldehyde) endoscopic forceps.  It 
was transported to the laboratory in Brain 
Heart Infusion
11 (BHI) soft agar tubes.  The 
biopsy specimen was transferred to modified 
BHI agar (Calf brain infusion – 200 g/l; 
Beef heart infusion – 250 g/l; Proteose 
peptone – 10 g/l; Dextrose – 2 g/l; NaCl – 5 
g/l; Disadium phosphate – 2.5 g/l; Agar – 15 
g/l; Triphenyl tetrazolium chloride – 40 
mg/l; Cefatoxime – 10 mg/ml; Defibrinated 
sheep blood – 50 ml; Final pH – 7.4 ± 0.2) 
plates and incubated at 37
0C under 
microaerophilic conditions for 72 – 96 h.   
Bacterial outgrowths from the biopsy 
specimen were characterized on the basis of 
culture, microscopic characteristics, 
biochemical and physiological properties.   
H.pylori was stored in modified BHI agar 
slants at 4
0C and used for this study. 
 
Extracts were incorporated aseptically in 
Standard, pre-sterilized filter discs
12 at a 
concentration of 5µl / disc.  Simultaneously, 
broth culture of human H.pylori isolates was 
seeded on air-dried sterile Muller-Hinton 
agar plates
12 using a sterile cotton swab.   
Filter discs were placed on the H.pylori 
inoculated plates with the help of flame 
sterilized forceps and pressed gently.  Plates 
were incubated at 37
0C under micro-
aerophilic condition for 48-72 h and zone of 
inhibition was recorded
13. 
 
Minimal inhibitory concentration (MIC) and 
determined as per standard methods
11.  For 
comparison, sterile filter discs with known 
concentration of antibiotics were obtained
10 
from Hi-media and used as standard 
antibacterial against Hp. 
 
RESULTS 
 
The zone of inhibition is given in table 1. 
Marginal inhibitory activity was observed in 
cold and hot aqueous extracts.  Among the 
samples, plant materials drawn during 
flowering season is found to possess slightly 
higher quality of inhibitory principles.  On 
the basis of MIC and MLC of variant II is 
observed to be potent against H.pylori.  
Chloroform extract of samples collected 
during flowering period showed both MIC 
and MLC at 40µg/ml, whereas for that 
during vegetative period the MIC was 
40µg/ml and MLC was 45µg/ml. 
 
Table II categorically demonstrates the 
emergence of multiple drug resistance in 
H.pylori.  In this the human H.pylori isolate 
has exhibited resistance to a wide class of 
bacteria’s, which includes pencillins, 
aminoglycosides with relatively low 
sensitivity to cephalsporins, such as 
ceftazimide. 
 
DISCUSSION 
 
Microbiological etiology of peptic ulcer was 
vague for a very long time.  Only in recent 
past the etiological correlation of Hp (earlier 
known as Campylobacter pyiori)
14 was 
proved which has brought about a change in 
PUD management
15.  In view of its inherent 
cost, patient compliance, side effect profiles 
and risk of drug resistant mutants, a search 
for therapeutic alternative for Hp eradication 
is on.  In this background, medicinal plant, 
which is traditionally used to treat PUD was 
screened against Hp. 
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Chloroform extracts were observed to be 
potent against Hp with relatively low MIC 
and MLC.  The terpenoidal fraction might 
posses the helicobactericidal activity.  Even 
though this is a promising candidate for 
eradication of Hp, its lower occurrence is 
indeed an inhibitory factor for its medicinal 
use in PUD
4,16.  Pharmacological studies 
were carried out previously on the 
cytoprotective activity17 which was found 
to increase potassium ion concentrations.   
This plays an important role in protecting 
the gastric and duodenal mucosa.  This 
result also support our finding wherein the 
increase in bicarbonates helps in building up 
of mucosal barrier against Hp.  Further 
characterization, structural elucidation and 
in-situ clinical evaluation on human 
volunteers will open a new view for the 
traditional usage, which would implement 
the therapeutic strategies for the eradication 
of the harboring bacteria of ulcerated site in 
the gastric tract. 
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Table I : Helicobactericidal activity of Cissus quadrangularis L. variant II 
 
Zone of inhibition (mm)  Extracts 
Vegetative period  Flowering period 
Control   -  - 
Cold extract  Trace  Trace 
Hot extract  -  Trace 
Acetone extract  1  3 
Chloroform extract  15  16 
Ethanol extract  Trace  Trace 
 
Zone of inhibition is given in m.m. 
-  -  No zone of inhibition 
Results are mean of 4 values 
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Table II. Antibiotic susceptibility pattern of human isolates of Helicobacter pylori 
 
Antibiotics tested  Concentration 
(ug/disc) 
Zone of 
inhibition (mm) 
R/S pattern 
Ciprofloxacin 5 38  S 
Amoxycillin 10  1  R 
Ampicillin 10  -  R 
Gentamycin 10  16  S 
Norfloxacin 10  31  S 
Streptomycin 10  12  I 
Cotrimoxazole 25  13  I 
Amikacin 30  18  S 
Ceftazidime 30  14  R 
Chloromphenicol 30  -  R 
Kanamycin 30  -  R 
Methicillin 30  -  R 
Netillin 30  14  R 
Tetracycline 30  12  R 
Tobramycin 30  23  S 
Vancomycin 30  -  R 
Nitrofurantoin 300  -  R 
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